Urinary 8-hydroxy-2′-deoxyguanosine, a metabolite of oxidized DNA, is not elevated in HIV patients on combination antiretroviral therapy

Free Radical Research

Volumn 37, Issue 5, 2003, Pages 499-502

  Paul, Simon ^a   Bogdanov, Mikhail B ^b   Matson, Wayne R ^c   Metakis, Linda ^b   Jacobs, Jonathan ^a   Beal, M Flint ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c ESA Biosciences Inc   (United States)

Author keywords

8 hydroxy 2 deoxyguanosine; Antiretroviral therapy; HIV; Lipodystrophy; Mitochondria

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ABACAVIR; ANTIRETROVIRUS AGENT; CARBON; CREATININE; DIDANOSINE; DNA; HYDROXYUREA; LAMIVUDINE; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL TRIAL; COLUMN CHROMATOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; CYTOTOXICITY; DNA DAMAGE; DNA METABOLISM; ELECTROCHEMICAL ANALYSIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; OXIDATION; OXIDATIVE STRESS; STATISTICAL SIGNIFICANCE; URINE LEVEL;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY CONSTITUTION; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DEOXYGUANOSINE; DNA DAMAGE; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; MALE; OXIDATIVE STRESS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0037402966     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/1071576031000076268     Document Type: Article

References (9)

1. Bogdanov, M.B., Beal, M.F., McCabe, D.R., Griffin, R.M. and Matson, W. (1999) "A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2′-deoxyguanosine measurements in urine and other biologic matrices: a one-year evaluation of methods", Free Radic. Biol. Med. 27, 647-666.
2. Brinkman, K., Hofstede, H.J.M., Burger, D.M., Smeitink, J.A.M. and Koopmans, P.P. (1998) "Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as a common pathway", AIDS 12, 1735-1744.
3. Brinkman, K., Smeitink, J.A.M., Romijn, J.A. and Reiss, P. (1999) "Mitochondrial toxicitiy induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy", Lancet 354, 1112-1115.
4. Garcia de la Asuncion, J., del Olmo, M.L., Sastre, J., Millan, A., Pellin, A. and Pallardo, F.V. (1998) "AZT treatment induces molecular and unltrastructural oxidative damage to muscle mitochondria", J. Clin. Investig. 102, 4-9.
5. Gaou, I., Malliti, M., Guimont, M.C., Letteron, P., Demeilliers, C., Peytaviin, G., Degott, C., Pessayre, D. and Fromenty, B. (2001) "Effect of stavudine on mitochondrial genome and fatty acid oxidation in lean and obese mice", J. Pharmacol. Exp. Ther. 297, 516-523.
6. Nolan, D., Hammond, E., Martin, A., Latham, B., Metcalf, C., John, M. and Mallal, S. (2001) NRTI Therapy is associated with mitochondrial DNA depletion, increased mitochondrial biogenesis, and subcutaneous fat wasting in HIV-infected patients. First International AIDS Society Conference on HIV Pathogenesis and Treatment, Buenos Aires, abstract 522.
7. Shikuma, C.M., Hu, N., Milne, C., Yost, F., Waslien, C., Shimizu, S. and Shiramizu, B. (2001) "Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy", AIDS 15, 1801-1809.
8. Bialkowska, A., Bialkowska, K., Gerschenson, M., Diwan, B.A., Jones, A.B., Olivero, O.A., Poirier, M.C., Anderson, L.M., Kasprzak, K.S. and Sipowicz, M.A. (2000) "Oxidative DNA damage in fetal tissues after transplacental exposure to 3′-azido-3′-deoxythymidine (AZT)", Carcinogenesis 21, 1059-1062.
9. Carr, A., Samaras, K., Thorisdottir, A., Kaufmann, G.R., Chrisholm, D.J. and Cooper, D.A. (1999) "Diagnosis, prediction and natural course of HIV-1 protease-inhibitor associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study", Lancet 353, 2093-2099.